These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

666 related articles for article (PubMed ID: 17013092)

  • 1. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
    Leiter U; Buettner PG; Eigentler TK; Garbe C
    J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic variables of cutaneous melanoma observed between 1995 and 2000 at Istituto Dermopatico Dell'Immacolata (IDI-IRCCS), Rome, Italy.
    Fortes C; Mastroeni S; Sera F; Concolino F; Abeni D; Melchi F; Forastiere F; Pasquini P
    Eur J Cancer Prev; 2006 Apr; 15(2):171-7. PubMed ID: 16523015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.
    Barnhill RL; Fine JA; Roush GC; Berwick M
    Cancer; 1996 Aug; 78(3):427-32. PubMed ID: 8697387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of localized melanoma by the exponential survival trees method.
    Huang X; Soong S; McCarthy WH; Urist MM; Balch CM
    Cancer; 1997 Mar; 79(6):1122-8. PubMed ID: 9070489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
    Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
    J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.
    Väisänen A; Kallioinen M; Taskinen PJ; Turpeenniemi-Hujanen T
    J Pathol; 1998 Sep; 186(1):51-8. PubMed ID: 9875140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological features and prognostic factors of cutaneous head and neck melanoma: a population-based study.
    Golger A; Young DS; Ghazarian D; Neligan PC
    Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):442-7. PubMed ID: 17515502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
    Eigentler TK; Buettner PG; Leiter U; Garbe C;
    J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.
    Sahin S; Rao B; Kopf AW; Lee E; Rigel DS; Nossa R; Rahman IJ; Wortzel H; Marghoob AA; Bart RS
    Cancer; 1997 Oct; 80(8):1426-31. PubMed ID: 9338466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
    Vollmer RT; Seigler HF
    Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
    Buettner PG; Leiter U; Eigentler TK; Garbe C
    Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
    Hoersch B; Leiter U; Garbe C
    Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
    Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
    Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI).
    Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR;
    Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.
    Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Singnomklao T; Ringborg U
    Cancer; 1997 Oct; 80(8):1418-25. PubMed ID: 9338465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.